On April 17, as the three-day in-cosmetics Global 2026 drew to a close in Paris, France, CIRS Group marked the end of its productive presence at the event. This annual gathering of the global personal care industry brought together over a thousand exhibitors and tens of thousands of professional visitors from around the world.
CIRS will attend In-cosmetics Global 2026 in Paris, providing cosmetic regulatory compliance, market access, and efficacy testing services at Stand 2D59.
In March 2026, the Shanghai Municipal, Fujian Provincial, Hubei Provincial, and Anhui Provincial Medical Products Administrations successively issued announcements regarding cosmetic supervision and sampling inspections. A total of 12 batches of products were found to be non-compliant. This summary of the announcements aims to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.
On March 25, 2026, the Korea Cosmetic Industry Association (KCIA) issued a notification regarding the Ministry of Food and Drug Safety's (MFDS) issuance of Notification No. 2026-16 to amend the "Regulation on Safety Standards, etc. for Cosmetics." The key amendments include the reorganization of hair dye ingredient lists, the addition of a new UV filter, and the revision of certain test methods. The amendments entered into effect on March 18, 2026.
From March 18 to 20, 2026, the three-day PCHi exhibition came to a successful close at the Hangzhou International Convention and Exhibition Center. As a key event in the global cosmetics, personal care, and home care industries, this year’s show brought together numerous leading domestic and international enterprises and industry elites.
Health Canada is implementing new regulations that will require cosmetic manufacturers to disclose specific fragrance allergens directly on product labels, marking a shift from current practices that allow fragrance ingredients to be listed collectively under "parfum" or "fragrance."
CIRS is delighted to announce that we will be exhibiting at the PCHi in Hangzhou, China between 18-20 March, 2026.
On February 2, 2026, the Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare, announced a revision to the annex of the Documentation Required for Case-by-Case Review of Applications for the Use of Human Cell-Derived Exosomes in Cosmetics. The revised annex takes effect immediately upon the date of announcement.
On November 24, 2025, the Taiwan Food and Drug Administration (TFDA) under the Ministry of Health and Welfare officially issued the testing method for Sudan dyes in cosmetics (Method No. RA03D015.001), which came into effect upon the date of publication.
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of October 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
Contact Us
